|
| Status |
Public on Dec 28, 2019 |
| Title |
BRCAness, SLFN11 and RB1 loss predict response to topoisomerase I inhibitors in triple negative breast cancers |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
Expression data from patient-derived xenografts of human triple-negative breast cancers
|
| |
|
| Overall design |
We used GeneChip Human 1.1 ST arrays to identify the genes differentially expressed in PDX with different responses to irinotecan treatment
|
| |
|
| Contributor(s) |
Marangoni E, Popova T |
| Citation(s) |
32075943 |
| Submission date |
Dec 27, 2019 |
| Last update date |
Dec 15, 2021 |
| Contact name |
Tatiana Popova |
| E-mail(s) |
Tatiana.Popova@curie.fr
|
| Phone |
+33156246965
|
| Organization name |
Institut Curie
|
| Lab |
INSERM U830
|
| Street address |
26 rue d'Ulm
|
| City |
Paris |
| State/province |
Veuillez choisir |
| ZIP/Postal code |
75248 |
| Country |
France |
| |
|
| Platforms (1) |
| GPL11532 |
[HuGene-1_1-st] Affymetrix Human Gene 1.1 ST Array [transcript (gene) version] |
|
| Samples (30)
|
|
| Relations |
| BioProject |
PRJNA597843 |
Less...
More...